Alpha1-antitrypsin therapy ameliorates acute colitis and chronic murine ileitis

BACKGROUND: Fecal alpha-1-antitrypsin (AAT) clearance has been a marker of clinical disease severity in inflammatory bowel diseases (IBD) for many years. While AAT deficiency is more often associated with lung and liver pathologies, AAT-deficient patients with concomitant IBD have been shown to deve...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Inflamm Bowel Dis
Main Authors: Collins, Colm B., Aherne, Carol M., Ehrentraut, Stefan F., Gerich, Mark E., McNamee, Eóin N., McManus, Martine C., Lebsack, Matthew D.P., Jedlicka, Paul, Azam, Tania, de Zoeten, Edwin F., Dinarello, Charles A., Rivera-Nieves, Jesús
Formato: Artigo
Idioma:Inglês
Publicado: 2013
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4654462/
https://ncbi.nlm.nih.gov/pubmed/23835442
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MIB.0b013e31829292aa
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares